Indivior Pharmaceuticals, Inc. (INDV) Total liabilities 2023–2025
Indivior Pharmaceuticals, Inc. (INDV) total liabilities at each fiscal year-end, per SEC filings.
$1.3BFY2025 · since FY2023: $1.9B → $1.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.3B | -21.3% |
| FY2024 | $1.7B | -14.9% |
| FY2023 | $1.9B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice